Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ABCA1 | O95477 | Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) | Disease related genesEnzymesFDA approved drug targets | 15 | Coronary atherosclerosisDyslipidemiaInborn lipid metabolism error | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.50 | ||
| AGRD1 | Q6QNK2 | Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Receptor-signaling mediation | 3 | 0.50 | |||
| AGRL2 | O95490 | Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1) | 7 | Receptor-signaling mediation | 3 | 0.50 | ||||
| AT1B3 | P54709 | Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3) (ATPB-3) (CD antigen CD298) | CD markersMetabolic proteinsPredicted intracellular proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.50 | |||
| B3A4 | Q96Q91 | Anion exchange protein 4 (AE 4) (Anion exchanger 4) (Sodium bicarbonate cotransporter 5) (Solute carrier family 4 member 9) | Metabolic proteinsPlasma proteinsPredicted membrane proteins | 11 | Fusion and delivery mediation | 3 | 0.50 | |||
| CAC1I | Q9P0X4 | Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3) | 24 | Fusion and delivery mediation | 3 | 0.50 | ||||
| CADM1 | Q9BY67 | Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1) | Human disease related genesPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 3 | 0.50 | |||
| CCR2 | P41597 | C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192) | CD markersG-protein coupled receptorsHuman disease related genes | 7 | Alzheimer diseaseArterial occlusive diseaseChronic kidney disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.50 | ||
| CD3E | P07766 | T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e) | CD markersDisease related genesFDA approved drug targets | 1 | Breast cancerMelanomaMycosis fungoides | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.50 | ||
| CKLF4 | Q8IZR5 | CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4) | Predicted membrane proteinsTransporters | 4 | Other mediation | 3 | 0.50 | |||
| CLCN5 | P51795 | H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5) | Disease related genesHuman disease related genesPlasma proteins | 10 | Clinical-translation mediationFusion and delivery mediation | 3 | 0.50 | |||
| CLD19 | Q8N6F1 | Claudin-19 | 4 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.50 | ||||
| F209A | Q5JX71 | Protein FAM209A | 1 | Other mediation | 3 | 0.50 | ||||
| F210B | Q96KR6 | Protein FAM210B, mitochondrial | Predicted intracellular proteinsPredicted membrane proteins | 2 | Immune mediation | 3 | 0.50 | |||
| FFAR4 | Q5NUL3 | Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1) | 7 | Fusion and delivery mediationImmune mediationMetabolism mediation | 3 | 0.50 | ||||
| FPR3 | P25089 | N-formyl peptide receptor 3 (FMLP-related receptor II) (FMLP-R-II) (Formyl peptide receptor-like 2) | 7 | Alzheimer disease | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 3 | 0.50 | |||
| GPR75 | O95800 | Probable G-protein coupled receptor 75 | 7 | Immune mediationReceptor-signaling mediation | 3 | 0.50 | ||||
| GRPR | P30550 | Gastrin-releasing peptide receptor (GRP-R) (GRP-preferring bombesin receptor) | 7 | Breast cancerIrritable bowel syndromeSolid tumour/cancer | Clinical-translation mediationReceptor-signaling mediation | 3 | 0.50 | |||
| GTR5 | P22732 | Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5) | Metabolic proteinsPlasma proteinsPredicted intracellular proteins | 12 | Fusion and delivery mediationImmune mediation | 3 | 0.50 | |||
| ITB1 | P05556 | Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29) | Cancer-related genesCD markersFDA approved drug targets | 1 | Brain cancerLung cancerRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.50 | ||
| KCNV1 | Q6PIU1 | Potassium voltage-gated channel subfamily V member 1 (Neuronal potassium channel alpha subunit HNKA) (Voltage-gated potassium channel subunit Kv8.1) | 6 | Fusion and delivery mediation | 3 | 0.50 | ||||
| MCLN1 | Q9GZU1 | Mucolipin-1 (ML1) (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1) (TRPML1) | Disease related genesHuman disease related genesPotential drug targets | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.50 | |||
| MRP5 | O15440 | ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) | Cancer-related genesEnzymesMetabolic proteins | 13 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 3 | 0.50 | |||
| NMDE2 | Q13224 | Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) | Disease related genesFDA approved drug targetsHuman disease related genes | 3 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.50 | |||
| PCDG3 | Q9Y5H0 | Protocadherin gamma-A3 (PCDH-gamma-A3) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 3 | 0.50 |